Cancer Cell· Si Shi, Miaoyan Wei, Nan Du, Jialin Li, Boyue Han, Wei Wang, Xin Hu, Fei Luo, Jin Xu, Xianjun Yu·· 16 天前精选评分52
HRS-4642联合阿得贝利单抗治疗经治转移性KRAS G12D突变胰腺癌的无化疗1/2期试验
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
导读
HRS-4642联合阿得贝利单抗在经治转移性KRAS G12D突变胰腺癌患者中的首个临床研究显示，该无化疗方案具有可控的安全性和初步抗肿瘤活性。
来源：Cancer Cell · cell.com